2013 Dade W. Moeller lecture: Medical countermeasures against radiological terrorism

Health Physics

Volumn 107, Issue 2, 2014, Pages 164-171

  Moulder, John E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

accidents; emergencies; nuclear; radiation effects radiological terrorism; radiological

Indexed keywords

ANIMAL; DRUG APPROVAL; ENVIRONMENTAL EXPOSURE; HUMAN; NUCLEAR ACCIDENT; RADIATION INJURY; RADIATION MONITORING; REVIEW; TERRORISM;

ANIMALS; DRUG APPROVAL; ENVIRONMENTAL EXPOSURE; HUMANS; RADIATION INJURIES; RADIATION MONITORING; RADIOACTIVE HAZARD RELEASE; TERRORISM;

EID: 84903705377     PISSN: 00179078     EISSN: 15385159     Source Type: Journal    
DOI: 10.1097/HP.0000000000000082     Document Type: Review

References (68)

1. -/- and wild-type female mice. Radiat Res 170:422-428; 2008.
2. Aebersold P. FDA experience with medical countermeasures under the Animal Rule. Adv Prev Med 2012:507-571; 2012.
3. Anno GH, McClellan GE, Dore MA. Protracted radiationinduced performance decrement. Volume 1: model development. Santa Monica, CA: Pacific-Sierra Research Corporation; 1995.
4. Anno GH, Young RW, Bloom RM, Mercier JR. Dose response relationships for acute ionizing-radiation lethality. Health Phys 84:565-575; 2003. (Pubitemid 36438204)
5. Baker JE, Moulder JE, Hopewell JW. Radiation as a risk factor for cardiovascular disease. Antiox Redox Signal 15:1945-1956; 2011.
6. Bertho JM, Roy L, Souidi M, Benderitter M, Gueguen Y, Lataillade JJ, Prat M, Fagot T, De Revel T, Gourmelon P. New biological indicators to evaluate and monitor radiationinduced damage: an accident case report. Radiat Res 169: 543-550; 2008. (Pubitemid 351671520)
7. Boerma M, Roberto KA, Hauer-Jensen M. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Rad Oncol Biol Phys 71:170-177; 2008.
8. Bourgier C, Levy A, Vozenin MC, Deutsch E. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics? Cancer Metas Rev 31:699-712; 2012.
9. Brown SL, Kolozsvary A, Liu J, Jenrow KA, Ryu S, Kim JH. Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat Res 173: 462-468; 2010.
10. Cohen EP, Bedi M, Irving AA, Jacobs ER, Tomic R, Klein JP, Lawton CA, Moulder JE. Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. Int J Rad Oncol Biol Phys 83:292-296; 2012.
11. Cohen EP, Fish BL, Moulder JE. Successful brief captopril treatment in radiation nephropathy. J Lab Clin Med 129: 536-547; 1997. (Pubitemid 27285050)
12. Dainiak N. Rationale and recommendations for treatment of radiation injury with cytokines. Health Phys 98:838-842; 2010.
13. Demidenko E, Williams BB, Swartz HM. Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiat Res 171:310-319; 2009.
14. Di Carlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. Development and licensure of medical countermeasures for platelet regeneration after radiation exposure. Radiat Res 176:134-137; 2011.
15. Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, Macvittie TJ. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res 179:89-100; 2013.
16. Fenech M. Current status, new frontiers and challenges in radiation biodosimetry using cytogenetic, transcriptomic and proteomic technologies. Radiat Measure 46:737-741; 2011.
17. Fliedner TM, Dörr HD, Meineke V. Multi-organ involvement as a pathogenetic principle of the radiation syndromes: a study involving 110 case histories documented in SEARCH and classified as the bases of haematopoietic indicators of effect. Brit J Radiol (Suppl) 27:1-8; 2005.
18. Garty G, Chen Y, Salerno A, Turner H, Zhang J, Lyulko O, Bertucci A, Xu Y, Wang H, Simaan N, Randers-Pehrson G, Yao YL, Amundson SA, Brenner DJ. The RABIT: a rapid automated biodosimetry tool for radiological triage. Health Phys 98: 209-217; 2010.
19. 5+ in mitigation and treatment of radiation-induced lung damage. Free Rad Biol Med 48:1034-1043; 2010.
20. Georges G, Lesnikov V, Jordan R, Lesnikova M, Yang JYL, Aragon A. Hematopoietic stem cells (HSC) survive and reconstitute hematopoiesis after 8 Gy total body irradiation (TBI) in dogs given intensive supportive care and cytokine treatment. In: Annual Meeting of the Radiation Research Society. Savannah, GA: RRS; 2009: 30-31.
21. Goans RE, Waselenko JK. Medical management of radiological casualties. Health Phys 89:505-512; 2005. (Pubitemid 41463884)
22. Hamama S, Gilbert-Sirieix M, Vozenin MC, Delanian S. Radiation-induced enteropathy: molecular basis of pentoxifyllinevitamin E anti-fibrotic effect involved TGF-beta(1) cascade inhibition. Radiother Oncol 105:305-312; 2012.
23. Jenkins P, Watts J. An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables. Int J Rad Oncol Biol Phys 80:1023-1029; 2011.
24. Jenrow KA, Liu JG, Brown SL, Kolozsvary A, Lapanowski K, Kim JH. Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis. J Neuro-Oncol 101:449-456; 2011.
25. Johnson CH, Patterson AD, Krausz KW, Kalinich JF, Tyburski JB, Kang DW, Luecke H, Gonzalez FJ, Blakely WF, Idle JR. Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res 178:328-340; 2012.
26. Jourdan MM, Olasz EB, Moulder JE, Fish BL, Mäder M, Schock A, Morrow N, Semenenko VA, Doctrow SR, Lazarova Z. Mitigation of combined radiation and skin wound injury by SOD/catalase mimetic EUK-207. In: Annual Meeting of the Radiation Research Society. Savannah, GA: RRS; 2009: 64-65.
27. Kharofa JR, Cohen EP, Tomic R, Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Rad Oncol Biol Phys 84:238-243; 2012.
28. Kim JH, Brown SL, Kolozsvary A, Jenrow KA, Ryu S, Rosenblum ML, Carretero OA. Modification of radiation injury by Ramipril, inhibitor of angiotensin converting enzyme, on optic neuropathy in the rat. Radiat Res 161: 137-142; 2004. (Pubitemid 38129806)
29. Kim JH, Kolozsvary A, Jenrow KA, Brown SL. Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice. Radiat Res 178:202-206; 2012.
30. Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH. Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res 168:440-445; 2007. (Pubitemid 351303172)
31. Koukourakis MI. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Brit J Radiol 85:313-330; 2012.
32. Lalkakis EC, Hyduke DR, Fornace AJ. Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide. Radiat Res 177:187-199; 2012.
33. Lam V, Moulder JE, Salzman NH, Dubinsky EA, Anderson GL, Baker JE. Intestinal microbiota as novel biomarkers of prior radiation exposure. Radiat Res 177:573-583; 2012.
34. Lee TC, Greene-Schloesser D, Payne V, Diz DI, Hsu FC, Kooshki M, Mustafa R, Riddle DR, Zhao W, Chan MD, Robbins ME. Chronic administration of the angiotensinconverting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat Res 178:46-56; 2012.
35. Lenarczyk M, Lam V, Jensen E, Fish BL, Su J, Kaprowski S, Komoriwski RA, Harmann L, Migrino RQ, Li XA, Hopewell JW, Moulder JE, Baker JE. Cardiac injury following 10 Gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res 180:247-258; 2013.
36. MacVittie TJ, Farese AM, Bennett A, Gelfond D, Shea-Donohue T, Tudor G, Booth C, McFarland E, Jackson W III. The acute gastrointestinal subsyndrome of the acute radiation syndrome: a rhesus macaque model. Health Phys 103: 411-426; 2012.
37. Mahmood J, Jelveh S, Zaidi A, Doctrow SR, Hill RP. Mitigation of radiation-induced lung injury with EUK-207 and genistein: effects in adolescent rats. Radiat Res 179: 125-134; 2012.
38. Medhora M, Gao F, Fish BL, Jacobs ER, Moulder JE, Szabo A. Dose-modifying factor for captopril for mitigation of radiation injury to normal lung. J Radiat Res 53:633-640; 2012.
39. Megid WA, Ensenberger MG, Halberg RB, Stanhope SA, Kent-First MG, Prolla TA, Bacher JW. A novel method for biodosimetry. Radiat Environ Biophys 46:147-154; 2007. (Pubitemid 46725995)
40. Ménard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 66:1844-1850; 2006. (Pubitemid 43259971)
41. Moroni M, Ngudiankama BF, Christensen C, Olsen CH, Owens R, Lombardini ED, Holt RK, Whitnall MH. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body irradiation. Int J Rad Oncol Biol Phys 86:986-992; 2013.
42. Mould RF. Chernobyl: the real story. Oxford, UK: Pergamon Press; 1988.
43. Moulder JE. Report on an interagency workshop on the radiobiology of nuclear terrorism. Radiat Res 158:118-124; 2002.
44. Moulder JE, Cohen EP. Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. Brit J Radiol (Suppl)27: 82-88; 2005.
45. Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Sem Rad Oncol 17:141-148; 2007. (Pubitemid 46467384)
46. Moulder JE, Cohen EP, Fish BL. Captopril and losartan for mitigation of renal injury caused by single-dose total body irradiation. Radiat Res 175:29-36; 2011.
47. Moulder JE, Cohen EP, Fish BL, Hill P. Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme. Radiat Res 136: 404-407; 1993. (Pubitemid 24029499)
48. Moulder JE, Fish BL, Cohen EP. Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy. Bone Marrow Transplant 19:729-736; 1997.
49. Moulder JE, Medhora M. Advances in mitigation of injuries from radiological terrorism or nuclear accidents. Def Sci J 61:99-104; 2011.
50. Otterson MF, Sarna SK, Moulder JE. The effects of radiation on gastrointestinal motility and potential therapies. In: MacVittie TJ, Weiss JF, Brownes D, eds. Advances in the treatment of radiation injuries. New York: Elsevier; 1996: 207-216.
51. Pellmar TC, Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 163: 115-123; 2005. (Pubitemid 40039952)
52. Prasanna PGS, Blakely WF, Bertho JM, Chute JP, Cohen EP, Goans RE, Grace MB, Lillis-Hearne PK, Lloyd DC, Lutgens LC, Meineke V, Ossetrova NI, Romanyukha A, Saba JD, Weisdorf DJ, Wojcik A, Yukihara EG, Pellmar TC. Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res 173:245-253; 2010.
53. Raber J, Rola R, Le Fevour A, Morhardt D, Curley J, Mizumatsu S, Van den Berg SR, Fike JR. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res 162: 39-47; 2004. (Pubitemid 39044717)
54. Riecke A, Rufa CG, Cordes M, Hartmann J, Meineke V, Abend M. Gene expression comparisons performed for biodosimetry purposes on in vitro peripheral blood cellular subsets and irradiated individuals. Radiat Res 178: 234-243; 2012.
55. Rojas-Palma C, Liland A, Jerstad AN, Etherington G, del Rosario Pérez M, Rahola T, Smith K. Triage, monitoring and treatment-handbook for management of the public in the event of malevolent use of radiation. Østerås, Norway: Norwegian Radiation Protection Agency; 2009.
56. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmoud J, Medhora M, Molthen R, Moulder JE, Sonis ST, Tofilon PJ, Doctrow SR. Salen Mn complexes mitigate radiation injury in normal tissues. Anti-Cancer Agents Med Chem 11:359-372; 2011.
57. Rothkamm K, Beinke C, Romm H, Badie C, Balagurunathan Y, Barnard S, Bernard N, Boulay-Greene H, Brengues M, De Amicis A, De Sanctis S, Greither R, Herodin F, Jones A, Kabacik S, Knie T, Kulka U, Lista F, Martigne P, Missel A, Moquet J, Oestreicher U, Peinnequin A, Poyot T, Roessler U, Scherthan H, Terbrueggen B, Thierens H, Valente M, Vral A, Zenhausern F, Meineke V, Braselmann H, Abend M. Comparison of established and emerging biodosimetry assays. Radiat Res 180:111-119; 2013.
58. Ryan JL, Krishnan S, Movsas B, Coleman CN, Vikram B, Yoo SS. Decreasing the adverse effects of cancer therapy: an NCI workshop on the preclinical development of radiation injury mitigators/protectors. Radiat Res 176: 688-691; 2011.
59. Sharma M, Moulder JE. The urine proteome as a radiation biodosimeter. Adv Exper Med Biol 990:87-100; 2013.
60. Singh VK, Ducey EJ, Brown DS, Whitnall MH. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol 88:296-310; 2012.
61. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, Dynan WS, Fike JR, Grdina DJ, Greenberger JS, Hauer-Jensen M, Hill RP, Kolesnick RN, Macvittie TJ, Marks C, McBride WH, Metting N, Pellmar T, Purucker M, Robbins ME, Schiestl RH, Seed TM, Tomaszewski JE, Travis EL, Wallner PE, Wolpert M, Zaharevitz D. Models for evaluating agents intended for the prophylaxis, mitigation, and treatment of radiation injuries. Report of an NCI workshop, December 3-4, 2003. Radiat Res 162:711-728; 2004. (Pubitemid 39552901)
62. Swartz HM, Flood AB, Gougelet RM, Rea ME, Nicolalde RJ, Williams BB. A critical assessment of biodosimetry methods for large-scale incidents. Health Phys 98:95-108; 2010.
63. van Dyk J, Keane TJ, Kan S, Rider WD, Fryer CJH. Radiation pneumonitis following large single dose irradiation: a reevaluation based on absolute dose to the lung. Int J Rad Oncol Biol Phys 7:461-467; 1981. (Pubitemid 11112799)
64. Vaurijoux A, Gregoire E, Roch-Lefevre S, Voisin P, Martin C, Voisin P, Roy L, Gruel G. Detection of partial-body exposure to ionizing radiation by the automatic detection of dicentrics. Radiat Res 178:357-364; 2012.
65. Vorotnikova E, Rosenthal RA, Tries M, Doctrow SR, Braunhut S. Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat Res 173:748-759; 2010.
66. Ward WF, Kim YT, Molteni A, Solliday NH. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. Int J Rad Oncol Biol Phys 15:135-140; 1988.
67. Wilcox DE, He X, Gui J, Ruuge AE, Li H, Williams BB, Swartz HM. Dosimetry based on EPR spectral analysis of fingernail clippings. Health Phys 98:309-317; 2010.
68. Williams BB, Dong R, Kmiec M, Burke G, Demidenko E, Gladstone D, Nicolalde RJ, Sucheta A, Lesniewski P, Swartz HM. Development of in vivo tooth EPR for individual radiation dose estimation and screening. Health Phys 98:327-338; 2010.